Shares of Vitalhub Corp. (TSE:VHI - Get Free Report) have received a consensus recommendation of "Buy" from the six brokerages that are covering the company, MarketBeat reports. Five equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is C$13.08.
A number of equities analysts have weighed in on the company. Raymond James set a C$13.50 target price on shares of Vitalhub and gave the stock an "outperform" rating in a research report on Thursday, March 27th. National Bankshares set a C$14.00 price objective on Vitalhub and gave the stock an "outperform" rating in a report on Tuesday. TD Securities upped their price target on shares of Vitalhub from C$13.00 to C$14.00 and gave the company a "buy" rating in a report on Monday, March 31st. Finally, National Bank Financial raised Vitalhub to a "strong-buy" rating in a research note on Monday.
Check Out Our Latest Stock Report on VHI
Insider Activity
In related news, Director Francis Nelson Shen acquired 25,000 shares of the firm's stock in a transaction that occurred on Friday, May 16th. The shares were purchased at an average price of C$10.23 per share, with a total value of C$255,750.00. Corporate insiders own 18.57% of the company's stock.
Vitalhub Trading Up 1.4%
VHI traded up C$0.15 during midday trading on Tuesday, reaching C$11.00. The company's stock had a trading volume of 144,322 shares, compared to its average volume of 132,052. Vitalhub has a 1 year low of C$6.74 and a 1 year high of C$12.34. The stock's 50-day moving average is C$10.34 and its 200-day moving average is C$10.62. The firm has a market capitalization of C$595.02 million, a price-to-earnings ratio of 178.91, a PEG ratio of 1.18 and a beta of 1.26.
About Vitalhub
(
Get Free ReportVitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Read More
Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
